AZ Groeninge Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00729872
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

AZ Groeninge Campus St.-Niklaas Kortrijk, Belgium

Active Ingredients

Drugs in Phase 2 Trials (1)

ag011 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1